151 related articles for article (PubMed ID: 10363795)
1. Experiments on a new phosphine-peptide chelator for labelling of peptides with Tc-99m.
Santimaria M; Blok D; Feitsma RI; Mazzi U; Pauwels EK
Nucl Med Biol; 1999 Apr; 26(3):251-8. PubMed ID: 10363795
[TBL] [Abstract][Full Text] [Related]
2. Tetraamine-derived bifunctional chelators for technetium-99m labelling: synthesis, bioconjugation and evaluation as targeted SPECT imaging probes for GRP-receptor-positive tumours.
Abiraj K; Mansi R; Tamma ML; Forrer F; Cescato R; Reubi JC; Akyel KG; Maecke HR
Chemistry; 2010 Feb; 16(7):2115-24. PubMed ID: 20066690
[TBL] [Abstract][Full Text] [Related]
3. Organometallic 99mTc(III) '4 + 1' bombesin(7-14) conjugates: synthesis, radiolabeling, and in vitro/in vivo studies.
Kunstler JU; Veerendra B; Figueroa SD; Sieckman GL; Rold TL; Hoffman TJ; Smith CJ; Pietzsch HJ
Bioconjug Chem; 2007; 18(5):1651-61. PubMed ID: 17663527
[TBL] [Abstract][Full Text] [Related]
4. Mixed tridentate π -donor and monodentate π -acceptor ligands as chelating systems for rhenium-188 and technetium-99m nitrido radiopharmaceuticals.
Boschi A; Uccelli L; Pasquali M; Pasqualini R; Guerrini R; Duatti A
Curr Radiopharm; 2013 Sep; 6(3):137-45. PubMed ID: 24106999
[TBL] [Abstract][Full Text] [Related]
5. New and versatile ternary ligand system for technetium radiopharmaceuticals: water soluble phosphines and tricine as coligands in labeling a hydrazinonicotinamide-modified cyclic glycoprotein IIb/IIIa receptor antagonist with 99mTc.
Edwards DS; Liu S; Barrett JA; Harris AR; Looby RJ; Ziegler MC; Heminway SJ; Carroll TR
Bioconjug Chem; 1997; 8(2):146-54. PubMed ID: 9095354
[TBL] [Abstract][Full Text] [Related]
6. Synthesis, characterization, and labeling with 99mTc/188Re of peptide conjugates containing a dithia-bisphosphine chelating agent.
Gali H; Hoffman TJ; Sieckman GL; Owen NK; Katti KV; Volkert WA
Bioconjug Chem; 2001; 12(3):354-63. PubMed ID: 11353532
[TBL] [Abstract][Full Text] [Related]
7. The influence of carrier on 99mTc radiopharmaceuticals.
Ballinger JR
Q J Nucl Med; 2002 Sep; 46(3):224-32. PubMed ID: 12134138
[TBL] [Abstract][Full Text] [Related]
8. In vitro and in vivo characterization of a 99mTc complex with tris(hydroxymethyl)phosphine (THP).
Berning DE; Katti KV; Singh PR; Higgenbotham C; Reddy VS; Volkert WA
Nucl Med Biol; 1996 Jul; 23(5):617-22. PubMed ID: 8905826
[TBL] [Abstract][Full Text] [Related]
9. Chemistry of the strong electrophilic metal fragment [(99)Tc(N)(PXP)](2+) (PXP = diphosphine ligand). A novel tool for the selective labeling of small molecules.
Bolzati C; Boschi A; Uccelli L; Tisato F; Refosco F; Cagnolini A; Duatti A; Prakash S; Bandoli G; Vittadini A
J Am Chem Soc; 2002 Sep; 124(38):11468-79. PubMed ID: 12236761
[TBL] [Abstract][Full Text] [Related]
10. Convenient preparation of no-carrier-added technetium-99m radiopharmaceuticals using solid-phase technology.
Dunn-Dufault R; Pollak A; Thornback JR; Ballinger JR
Bioconjug Chem; 1999; 10(5):832-7. PubMed ID: 10502350
[TBL] [Abstract][Full Text] [Related]
11. Phosphine-containing HYNIC derivatives as potential bifunctional chelators for (99m)Tc-labeling of small biomolecules.
Purohit A; Liu S; Casebier D; Edwards DS
Bioconjug Chem; 2003; 14(4):720-7. PubMed ID: 12862424
[TBL] [Abstract][Full Text] [Related]
12. Synthesis, characterization, and biological evaluation of neutral nitrido technetium(V) mixed ligand complexes containing dithiolates and aminodiphosphines. A novel system for linking technetium to biomolecules.
Bolzati C; Benini E; Cazzola E; Jung C; Tisato F; Refosco F; Pietzsch HJ; Spies H; Uccelli L; Duatti A
Bioconjug Chem; 2004; 15(3):628-37. PubMed ID: 15149191
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of single amino acid chelate derivatives and regioselective radiolabelling of a cyclic peptide for the urokinase plasminogen activator receptor.
Armstrong AF; Lemon JA; Czorny SK; Singh G; Valliant JF
Nucl Med Biol; 2009 Nov; 36(8):907-17. PubMed ID: 19875047
[TBL] [Abstract][Full Text] [Related]
14. Combining bifunctional chelator with (3 + 2)-cycloaddition approaches: synthesis of dual-function technetium complexes.
Braband H; Imstepf S; Benz M; Spingler B; Alberto R
Inorg Chem; 2012 Apr; 51(7):4051-7. PubMed ID: 22416667
[TBL] [Abstract][Full Text] [Related]
15. The Past, Current Studies and Future of Organometallic 99mTc(CO)3 Labeled Peptides and Proteins.
Piramoon M; Hosseinimehr SJ
Curr Pharm Des; 2016; 22(31):4854-4867. PubMed ID: 27339431
[TBL] [Abstract][Full Text] [Related]
16. Efficient preparation of (99m)Tc(III) '4+1' mixed-ligand complexes for peptide labeling with high specific activity.
Kunstler JU; Seidel G; Pietzsch HJ
Appl Radiat Isot; 2010 Sep; 68(9):1728-33. PubMed ID: 20430637
[TBL] [Abstract][Full Text] [Related]
17. Copper-free click bioconjugation of technetium-99m complexes using strained cyclononyne derivatives.
Schlesinger M; Jentschel C; Pietzsch HJ; Kopka K; Mamat C
Dalton Trans; 2023 Mar; 52(10):3024-3032. PubMed ID: 36779384
[TBL] [Abstract][Full Text] [Related]
18. Construction of a novel chimera consisting of a chelator-containing Tat peptide conjugated to a morpholino antisense oligomer for technetium-99m labeling and accelerating cellular kinetics.
Zhang YM; Tung CH; He J; Liu N; Yanachkov I; Liu G; Rusckowski M; Vanderheyden JL
Nucl Med Biol; 2006 Feb; 33(2):263-9. PubMed ID: 16546682
[TBL] [Abstract][Full Text] [Related]
19. A solid-phase technique for preparation of no-carrier-added technetium-99m radiopharmaceuticals: application to the streptavidin/biotin system.
Dunn-Dufault R; Pollak A; Fitzgerald J; Thornback JR; Ballinger JR
Nucl Med Biol; 2000 Nov; 27(8):803-7. PubMed ID: 11150714
[TBL] [Abstract][Full Text] [Related]
20. Mixed-ligand technetium(III) complexes with tetradendate/monodendate NS(3)/isocyanide coordination: a new nonpolar technetium chelate system for the design of neutral and lipophilic complexes stable in vivo.
Pietzsch HJ; Gupta A; Syhre R; Leibnitz P; Spies H
Bioconjug Chem; 2001; 12(4):538-44. PubMed ID: 11459458
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
